Tools
Stock profile

TELEFLEX INC (TFX)

TFX · Latest close $165.85 as of Nov 18, 2026 · 13F data as of Jun 30, 2026 (2026 Q2)
Latest close
$165.85
As of Nov 18, 2026
Tracked funds holding
4 of 149
2026 Q2 13F filings
Opened / added
0 / 0
vs previous quarter
Trimmed / exited
3
vs previous quarter

TELEFLEX INC (TFX) is held by 4 of 149 tracked super-investor funds (144 filed in Q2) in 2026 Q2 13F filings, with 3 funds trimming or exiting versus the previous quarter. Latest close $165.85 as of Nov 18, 2026.

Data as of Nov 18, 2026 (prices) · 2026 Q2 13F filings (quarter ended Jun 30, 2026) · Latest Form 4: none in the last 90 days · Congress to Nov 16, 2026.

Funds
2026 Q2 13F
Fundamentals
Revenue · FY2025
Red flags
none flagged
Short interest
as of Oct 15, 2026
Holdings · Charts · All institutions · Fundamentals · Short interest · Fails to deliver · Insider trading · 5% holders · Planned sales · Politician trading · Committee jurisdiction · Government relations · Screens & lenses · Signal record · Related stocks · Recent 8-K

Funds holding this

Abrams Bison Investments · Baupost Group · Sessa Capital — 4 tracked funds hold TFX. See all holders.

Insider and Congress activity

No insider open-market activity or Congress trades reported for this stock in the recent window. Insider trading · Politician trading.

Often held alongside

CAPITAL ONE FINANCIAL CORP (COF) · BECTON DICKINSON & CO (BDX) · BOSTON SCIENTIFIC CORP (BSX) · BAXTER INTERNATIONAL INC (BAX) · STRYKER CORP (SYK) — stocks the same funds also hold. See all related stocks.

Super-investor holdings · 2026 Q2

FundPortfolio weightSharesChange vs prev. quarter
Abrams Bison Investments4.91%793,000TRIMMED (-20.7%) Q3 filed Nov 16
Baupost Group3.30%1,409,000TRIMMED (-11.7%) Q3 filed Nov 13
Sessa Capital3.24%1,526,228HELD Q3 filed Nov 16
Pzena Investment Management0.22%603,206TRIMMED (-13.7%) Q3 filed Oct 30

Source: SEC Form 13F filings, quarter ended Jun 30, 2026. Change labels compare each fund’s 2026 Q2 filing with its previous filing. Fund counts aggregate every share class mapped to this ticker.

Price change since quarter-end: +23.0% from the close on the first trading day after the quarter ended (Jul 1, 2026) to the latest close (Nov 17, 2026). 13F does not report purchase prices — this is the price change since the quarter-end close, not a gain on any fund’s actual purchase.

Filing season: the Q3 2026 13F tracker follows every tracked fund’s filing for the quarter ended Sep 30, 2026, with its biggest buys and sells.

Charts

194.6496.572024-11-192026-11-18

Closing prices (unadjusted for dividends), last 2 years — 501 trading days to Nov 18, 2026. Dashed lines mark 13F filing deadlines. Source: Yahoo Finance daily bars.

All institutions · Form 13F

Institutions holding381 of 8,857 filers
Long-only filers among them381
Change vs 2026 Q1+23 net · 374 entered · 351 exited
Shares reported, all filers47,931,918
Reported value, all filers$5.4B

Source: SEC Form 13F data sets — every filer's latest report for the quarter ended Jun 30, 2026, not just the tracked funds above; changes compare with the quarter ended Mar 31, 2026. Share counts and values are summed as reported in the filings (a small number of filers report values in thousands of dollars, so value totals are as-filed sums).

Company fundamentals

ExchangeNYSE
IndustrySurgical & Medical Instruments & Apparatus (SIC 3841)
Revenue · FY2025$2.0B
Net income · FY2025$-905.6M
Total assets · FY2025$6.9B
Shares outstanding42,372,397
Market cap (at latest close)$7.0B

Source: SEC EDGAR company filings (submissions and company facts), collected Oct 30, 2026. Shares outstanding as reported Aug 4, 2026.

Short interest

Shares short · Oct 15, 20264,217,563
Share of shares outstanding9.95%
Days to cover5.98

Shares short at recent settlements — Jul 31, 2026: 3.0M · Aug 14, 2026: 4.8M · Aug 31, 2026: 4.0M · Sep 15, 2026: 4.0M · Sep 30, 2026: 4.1M · Oct 15, 2026: 4.2M.

Source: FINRA Equity Short Interest (biweekly settlement data). Shares outstanding from SEC filings as of Aug 4, 2026.

Fails to deliver

Shares failed to deliver · Oct 14, 20260
Share of shares outstanding0.00%
Fails as a share of short interest · Oct 15, 20260.0%

Fails to deliver at recent settlements — Jul 31, 2026: 433 · Aug 14, 2026: 6 · Aug 31, 2026: 548 · Sep 15, 2026: 0 · Sep 30, 2026: 0 · Oct 14, 2026: 0.

Source: SEC Fails-to-Deliver data (semi-monthly files, published about two weeks after each settlement date). Each figure is the balance of shares not yet delivered on that date; a stock absent from that date’s file counts as zero. See our research on whether fails to deliver predict returns. Shares outstanding from SEC filings as of Aug 4, 2026.

Insider trading · Form 4

Data unavailable — no Form 4 transactions for this ticker were parsed in the last 90 days.

Planned sales · Form 144

FiledSellerRoleShares to sellMarket valueApprox. sale dateSource
Aug 16, 2024RANDLE STUART ADirector2,674$638.9KAug 16, 2024SEC filing
Mar 1, 2024Hicks Cameron POfficer7,401$1.7MMar 1, 2024SEC filing
Dec 27, 2023LIAM KELLYOfficer, Director26,256$6.6MDec 27, 2023SEC filing
Nov 29, 2023POWELL THOMAS EOfficer13,952$3.1MNov 29, 2023SEC filing
May 10, 2023RANDLE STUART ADirector3,021$742.3KMay 10, 2023SEC filing

A Form 144 notice is a planned sale, not a completed sale. Most recent first. Source: SEC Form 144 filings, 63,013 notices from Apr 13, 2023 to Oct 9, 2026.

5% holders · Schedule 13D/G

FiledFilerFormShares% ownedEvent dateSource
Sep 8, 2026JANUS HENDERSON GROUP Ltd.SC 13G/A4,343,76410.3%Aug 31, 2026SEC filing
Aug 14, 2026T. Rowe Price Investment Management, Inc.SC 13G/A3,194,7107.2%Jun 30, 2026SEC filing
May 15, 2026T. Rowe Price Investment Management, Inc.SC 13G/A3,836,2078.7%Mar 31, 2026SEC filing
Apr 30, 2026Vanguard Capital ManagementSC 13G2,324,5765.2%Mar 31, 2026SEC filing
Apr 29, 2026Vanguard Portfolio ManagementSC 13G2,458,6235.6%Mar 31, 2026SEC filing
Mar 27, 2026The Vanguard GroupSC 13G/A00.0%Mar 13, 2026SEC filing
Feb 12, 2026AQR Capital Management, LLCSC 13G/A1,923,2084.3%Dec 31, 2025SEC filing
Feb 11, 2026Morgan StanleySC 13G/A2,162,4074.9%Dec 31, 2025SEC filing
Nov 14, 2025T. Rowe Price Investment Management, Inc.SC 13G/A4,569,04310.3%Sep 30, 2025SEC filing
Nov 14, 2025AQR Capital Management, LLCSC 13G2,366,1315.3%Sep 30, 2025SEC filing

One filing is one row; a filing may list several reporters and the first is shown. Figures are as filed, including amendments that report zero shares after a transfer. Source: SEC Schedule 13D/G filings, 57,443 filings parsed to Oct 2, 2026.

Politician trading · U.S. Congress

Data unavailable — no congressional STOCK Act transactions for this ticker were parsed in the current window (as of Nov 16, 2026).

Committee jurisdiction

Industry: Surgical & Medical Instruments & Apparatus (SIC 3841). Standing committees with jurisdiction over this industry: Senate Committee on Health, Education, Labor, and Pensions, House Committee on Energy and Commerce.

None of the members who traded this stock in the current window sit on these committees.

Assignments are the current (119th Congress) rosters. A trade made in an earlier Congress may have been made under a different assignment. Jurisdiction is by industry (SEC SIC code), not by anything the company said or did. Same rule as our committee-jurisdiction study.

Government relations

Lobbying: 114 Lobbying Disclosure Act filings named this company as client, 1999–2026; most common issues: Defense (54), Health Issues (36), Medicare/Medicaid (34).

Federal contracts: $10.2M in obligated amounts, fiscal years 2021–2026.

Fiscal yearObligated amount
FY2021$1.3M
FY2022$2.6M
FY2023$6.1M
FY2024$156.6K
FY2025$0
FY2026$31.7K

Largest awards collected

Award IDAgencyAmountStart
SPE2DS21V9282Department of Defense$192.5KSep 14, 2021
36C26224P2106Department of Veterans Affairs$135.8KAug 16, 2024
36C25720C0016Department of Veterans Affairs$132.3KDec 11, 2019
W81K0024P0046Department of Defense$132.1KFeb 8, 2024
36C25025P1209Department of Veterans Affairs$126.6KJun 6, 2025

Lobbying filings are matched by company core name; a filing can match more than one ticker. Contract amounts are obligated amounts (money committed, not money spent), matched by recipient name — contracts under a subsidiary’s name can be missed. Sources: Senate Lobbying Disclosure Act filings; USAspending.gov. See Methodology.

Screens & lenses

Financial Screens

· Dividend Growth — Dividends raised for more than 10 years

· Shareholder Yield — Cash returned through dividends and buybacks

Chart Signals

· Monthly Uptrend — Price above its 12-month moving average

· 52-Week High — Recently printed a new 52-week high

· Top Relative Strength — Top 20% of the universe by 6-month return

Key figures

· Dividend Growth — Dividend per share: 1.36 · Dividend yield: 1.0% · Straight dividend years: 18 · 10-yr dividend growth: 0.0%

· Shareholder Yield — Shareholder yield: 5.7% · of which dividends: 0.9% · of which buybacks: 4.7%

Financial screens are computed from SEC company financial statements; red-flag models are screens, not verdicts — see Methodology.

Signal record

· Insider BEST — appeared in 1 of the last 20 quarterly lists; latest 2025 Q3, ranked #15 of 50.

Also held by the tracked funds that hold TFX — ranked by lift, the co-holding pattern described in Methodology: CAPITAL ONE FINANCIAL CORP (COF) · BECTON DICKINSON & CO (BDX) · BOSTON SCIENTIFIC CORP (BSX) · BAXTER INTERNATIONAL INC (BAX) · STRYKER CORP (SYK) · Solventum Corp (SOLV) · Medline Inc. (MDLN) · 3M CO (MMM).

7 of the 8 are same-industry (SIC) fillers: fewer than 4 stocks met the lift rule for this stock.

Recent 8-K filings

FiledItemsSource
Nov 5, 20262.02 Results of Operations and Financial Condition · 7.01 Regulation FD Disclosure · 9.01 Financial Statements and ExhibitsSEC filing
Sep 9, 20265.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers · 7.01 Regulation FD Disclosure · 9.01 Financial Statements and ExhibitsSEC filing
Aug 7, 20268.01 Other EventsSEC filing

Source: SEC EDGAR Form 8-K filings, latest first. Amendments (Form 8-K/A) are labeled as such. Item labels are the SEC's item titles; a filing can carry several items. Item 5.02 covers both departures and appointments, which this index does not distinguish.

Related

CAPITAL ONE FINANCIAL CORP (COF) · Track Record: how the signals scored · Practice timing on TFX

One email a week: the week’s new filings and research. Subscribe free

← TFIN  ·  TGB →

Open the interactive tool →Live screens, charts and backtests for every tracked stock, fund and signal — free, no sign-up.